Screening of Hepatitis B and Hepatitis C in a tertiary care center of Bihar
Keywords:Screening, Hepatitis B, Hepatitis C
Introduction: It is estimated that 325 million people worldwide are living with chronic HBV or HCV infection. The risk of chronicity is more in neonates (90%) and young children (20-60%) than in infection that is acquired in adulthood (5%). Methodology: This study was conducted at Jawahar Lal Nehru Medical College & Hospital, Bhagalpur, Bihar, India by the Department of Microbiology during the study period of 1 year from January 2021 to December 2021. Patients’ samples were obtained from various outdoor patient departments & Indoor wards and were tested for HbsAg or Anti HCV antibody on Enzyme linked immunosorbent assay (ELISA) test. Five milliliter of blood was collected and serum was separated which was divided into two aliquots; one was used for HbsAg and the other was used for anti-HCV antibody for ELISA testing. In total, 1000 samples were collected and tested for HbsAg and anti HCV antibody. Prior approval was obtained from the Institutional Ethics Committee. Collected data was tabulated and analyzed using SPSS ver. 21.0. Collected data was tabulated and analyzed using SPSS ver. 21.0. Results: A total of 1000 samples were collected and tested during the study duration. On analysis of collected samples, the prevalence of HbsAg was 6.12% which is higher in comparison to other parts of India where usually maximally it has been reported to around 4%. In case of anti HCV antibodies the prevalence was 5.89% which is greater than expected in India where it was thought to be around 1%. Conclusion: Availability of sufficient recent estimates of HBV or HCV prevalence is necessary to evaluate control measures and health care planning.
How to Cite
Copyright (c) 2022 Sweta Gupta, Ranjan Kumar, Ashif Ali Hassan
This work is licensed under a Creative Commons Attribution 4.0 International License.